AB1148 PATIENT AND PHYSICIAN GLOBAL ASSESSMENT OF PSORIATIC ARTHRITIS APPEAR MORE IN AGREEMENT IN ARAB COUNTRIES THAN PREVIOUSLY REPORTED ELSEWHERE – AN INTERNATIONAL STUDY UNDER THE AEGIS OF ARLAR
Authors: N. Ziade, N. Abbas, L. Kibbi, A. Maroof, B. Zorkany, N. A. Al-Ani, A. Ridha, N. Ihsan, F. Isho Gorial, N. Al Chama, C. Haouichet, F. Alnaimat, S. Hannawi, S. Atawina, H. Halabi, M. Mashaleh, L. Aljazwi, A. Abogamal, L. Ayoub, E. Bouajina, R. Bahiri, S. Saad, M. Sabkar, K. Aouad, L. Gossec, I. Hmamouchi
Journal: Annals of the Rheumatic Diseases (2023)

<h3>Background</h3> In patients with psoriatic arthritis (PsA), discordance between physicians and patients when assessing disease activity has been described as frequent, mainly in European and North American studies. This discordance may negatively impact treatment adherence and shared decision-making processes. Culture and beliefs influence patients' perceptions of health. <h3>Objectives</h3> To evaluate the concordance between patient- (PGA) and physician-global assessment (PhGA) of PsA disease activity and its association with demographic and disease characteristics in a multinational group of patients from Arab countries. <h3>Methods</h3> This multicentric multinational cross-sectional study was conducted in thirteen Arab countries by the Arab League of Associations of Rheumatology (ArLAR) research group (ARCH). During a single routine visit, patients and physicians were requested to rate the PsA disease activity on a numeric scale from 0 (no activity) to 10 (worse activity). In addition, demographic and disease data were collected, as well as PGA and PhGA for psoriasis (PsO) activity, Health Assessment Questionnaire (HAQ), Fibromyalgia Rapid Screening Tool (FiRST), Patient Health Questionnaire (PHQ4) and Disease Activity in Psoriatic Arthritis (DAPSA). First, the correlation between PGA and PhGA for PsA and PsO disease activity was assessed statistically using the Spearman correlation coefficient (PsA and PsA) and graphically using the Bland and Altman method (PsA). Second, concordance between the PGA and PhGA PsA activity (defined as a difference between -2 and 2) was calculated and correlated with demographic and disease factors using multivariable binary logistic regression. <h3>Results</h3> The study included 554 patients from thirteen countries: mean age 45 years (SD 13), 57% females, median disease duration four years (IQR 2-9); 89.2% had skin PsO, and 43.5% had nail PsO. The disease was active overall: mean DAPSA was 19.3 (SD 16.1), HAQ 1.1 (SD 0.8), and PHQ4 3.3 (SD 2.9). The screening test for widespread pain was positive in 18.4% of patients. The mean PGA for PsA activity was 4.7 (SD 2.5), versus a PhGA of 3.9 (SD 2.4). Similarly, PGA for psoriasis activity was 4.0 (SD 2.8), and PhGA was 3.1 (SD 2.6). The correlation between PGA and PhGA was strong for PsA activity (r= 0.738) (with good agreement on Bland and Altman (Figure 1)) and moderate for psoriasis activity (r=0.613). Among 554 patients' measurements, 358 (84.2%) were in concordance with the physician's global assessment. In the multivariable analysis, concordance was independently associated with a high CRP (OR 2.32 [95%CI 1.33; 4.02] and DAPSA category (better concordance in patients in remission (OR 1.02 (95%CI 1.01; 1.03]). <h3>Conclusion</h3> In this unselected sample of patients from Arab countries, there was a strong concordance between PGA and PhGA of PsA activity. This raises questions about patient expectations and pain perceptions in Arab countries. Concordance was stronger for PsA than PsO, indicating that rheumatologists may be more comfortable assessing joints than skin. The patient's evaluation of disease activity needs to be taken into account when considering the disease management plan, especially in patients who are not in remission. <h3>Acknowledgements</h3> Dr Suad Hashad, Ms Arlyn Lim Acenas. <h3>Disclosure of Interests</h3> None Declared.